Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database
EUROPEAN JOURNAL OF ENDOCRINOLOGY, vol.152, no.4, pp.581-587, 2005 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 152 Issue: 4
- Publication Date: 2005
- Doi Number: 10.1530/eje.1.01881
- Journal Name: EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.581-587
- Istanbul University Affiliated: No
Abstract
Objective: Sheehan's syndrome occurs as a result of ischaemic pituitary necrosis due to severe postpartum haemorrhage. It is one of the most important causes of hypopituitarism. and hence growth hormone deficiency (GHD), in developing countries. However, little is known about the effects of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.